CVS Health Corporation (CVS) : The highest short term price target forecast on CVS Health Corporation (CVS) is $123 and the lowest target price is $90. A total of 21 equity analysts are currently covering the company. The average price of all the analysts is $111.88 with a standard deviation of $7.5.
CVS Health Corporation (CVS) : The consensus on CVS Health Corporation (CVS) based on 20 analyst recommendation on the company stock is 1.45, which is interpreted as a Strong Buy recommendation. Zacks Investment Research has issued a rank of 3 which endorses a Hold on the stock. However, 15 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 1 analyst believes that the stock is a Buy, which can produce decent returns in the future. 4 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating.
Also, Major Brokerage house, Citigroup maintains its ratings on CVS Health Corporation (NYSE:CVS). In the latest research report, Citigroup lowers the target price from $115 per share to $108 per share. According to the latest information available, the shares are now rated Neutral by the analysts at the agency. The rating by the firm was issued on August 8, 2016.
CVS Health Corporation (NYSE:CVS): The stock opened at $93.56 on Thursday but the bulls could not build on the opening and the stock topped out at $93.75 for the day. The stock traded down to $93.07 during the day, due to lack of any buying support eventually closed down at $93.37 with a loss of -0.03% for the day. The stock had closed at $93.40 on the previous day. The total traded volume was 3,274,393 shares.
CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise, including over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, photo finishing, seasonal merchandise and greeting cards through the Companys retail stores, online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company, through its wholly owned subsidiary, Omnicare, Inc., provides pharmacy services to long term care facilities.